- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05207631
Intervention to Reduce Misused Inhaler and Insufficient Peak Inspiratory Flow in Hospitalized COPD Patients (MIPIF)
Misused Inhaler and Insufficient Peak Inspiratory Flow in Hospitalized COPD Patients Before and After Implementation of a Systematic Assessment and a Prescription Guide - a Quasi Experimental Study - MIPIF
The drug treatment of chronic obstructive pulmonary disease (COPD) is mainly based on inhaled therapy. This route of administration is limited by inhaler handling errors, insufficient inspiratory flow or inappropriate inhalers. According to the scientific literature, these limitations are extremely common in both outpatients and inpatients.
Our hypothesis is that the implementation of a standardised and systematic assessment of inhalers combined with a prescribing guide to help select a suitable inhaler will decrease the proportion of suboptimally used inhalers at discharge in patients hospitalised with a diagnosis of COPD.
To assess the effectiveness of our intervention, the investigators will compare the proportion of inhalers used suboptimally at hospital discharge between a control cohort before the implementation of our intervention and a cohort after the implementation of our intervention. Secondary outcomes include reasons for sub-optimal use of inhalers, i.e. inhaler handling errors, insufficient peak inspiratory flow or inappropriate inhaler. Secondary outcomes will also include length of hospital stay and 30-day readmission rate.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Fribourg, Switzerland, 1700
- HFR Fribourg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Admission to the HFR Fribourg internal medicine department
- Age greater than or equal to 18 years
- Diagnosis of COPD
- Use of an inhaler device for the treatment of COPD before admission
Exclusion Criteria:
- Inability to complete initial assessment due to language problems
- Inability to complete initial assessment due to physical or mental conditions
- Patient who has already received the intervention during a previous hospitalization.
- Length of hospitalization of less than 72 hours
- Patient already included in the control period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control cohort
Participants in the control cohort received standard care.
|
|
Active Comparator: Cohort with intervention
Participants included in the intervention cohort receive a systematic and standardised assessment of their inhaler on admission to our department.
Their inhalers are adapted in accordance with a prescribing guide.
|
Participants included in the intervention cohort receive a systematic and standardised assessment of their inhalers on admission to our department.
The assessment is carried out by a physiotherapist and aims to assess inhalation technique, peak inspiratory flow and ability to use the inhaler after targeted teaching.
Based on this information and a prescription guide provided, the patient's doctor can select the most appropriate inhaler.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of inhalers used sub-optimally at hospital discharge
Time Frame: This outcome is assessed within 48 hours prior to hospital discharge
|
An inhaler used sub-optimally is defined as an inhaler used with at least one critical error and/or with insufficient inspiratory flow.
|
This outcome is assessed within 48 hours prior to hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of inhaler used with a critical error at hospital discharge
Time Frame: This outcome is assessed within 48 hours prior to hospital discharge
|
In accordance with the literature, the investigators define critical error as an action or an inaction that in itself would have a detrimental impact of the delivery of the drug to the distal airways.
|
This outcome is assessed within 48 hours prior to hospital discharge
|
Proportion of inhaler used with suboptimal peak inspiratory flow at hospital discharge.
Time Frame: This outcome is assessed within 48 hours prior to hospital discharge
|
The peak inspiratory flow values considered sub-optimal for inhaler use are defined in the literature and are specific to each inhaler type.
|
This outcome is assessed within 48 hours prior to hospital discharge
|
Proportion of inhalers that cannot be handled properly despite appropriate teaching at hospital discharge.
Time Frame: This outcome is assessed within 48 hours prior to hospital discharge
|
If critical errors are identified in the handling of the inhaler, the physiotherapist provides targeted instruction to correct these errors.
After each instruction, a new assessment of the inhaler technique is performed and the instruction is repeated if a critical error persists.
If handling critical errors persist despite appropriate instruction, it's considered that the inhaler cannot be handled by the patient.
|
This outcome is assessed within 48 hours prior to hospital discharge
|
Proportion of inappropriate inhaler at hospital discharge.
Time Frame: This outcome is assessed within 48 hours prior to hospital discharge
|
An inhaler is considered unsuitable if the patient is unable to handle it properly after appropriate instruction and/or if the patient does not have sufficient inspiratory flow for optimal use of the inhaler.
|
This outcome is assessed within 48 hours prior to hospital discharge
|
Proportion of inhalers used sub-optimally at hospital discharge by type of inhaler.
Time Frame: This outcome is assessed within 48 hours prior to hospital discharge
|
The proportion of inhalers used sub-optimally at hospital discharge is described by type of inhaler.
|
This outcome is assessed within 48 hours prior to hospital discharge
|
Proportion of patients using at least one inhaler sub-optimally
Time Frame: This outcome is assessed within 48 hours prior to hospital discharge
|
A participant is considered to have suboptimal device use if making a critical error when using an inhaler or if their peak inspiratory flow rate is insufficient for optimal device use.
|
This outcome is assessed within 48 hours prior to hospital discharge
|
Length of hospital stay
Time Frame: This outcome is assessed up to three months
|
The length of stay in acute care on the internal medicine department will be documented.
|
This outcome is assessed up to three months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gaël Grandmaison, Dr, Hôpital Fribourgeois
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 010322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Not yet recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
University Hospital, BrestRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Baylor Research InstituteNot yet recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
Clinical Trials on Systematic and standardised assessment of inhalers and implementation of a prescribing guide
-
Centre Francois BaclesseFrench cancer Institute INCaRecruitingThyroid Cancer | Intermediate RiskFrance
-
Emory UniversityNational Institute of General Medical Sciences (NIGMS)Not yet recruiting
-
Central Hospital, Nancy, FranceRecruitingPeripheral Venous AccessFrance
-
Palo Alto Veterans Institute for ResearchUnited States Department of DefenseCompletedPosttraumatic Stress DisorderUnited States
-
Nova Scotia Health AuthorityDalhousie UniversityNot yet recruitingNeisseria Gonorrheae Infection | Chlamydia Trachomatis InfectionCanada
-
Hospital de GranollersCompletedColorectal Neoplasms | Surgical Wound InfectionSpain
-
Parc de Salut MarFondo de Investigacion SanitariaUnknown
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenRecruiting
-
Nantes University HospitalCompletedAnorexia NervosaFrance
-
Oscar Diaz-CambroneroInstituto de Investigacion Sanitaria La Fe; INCLIVACompletedNeuromuscular BlockadeSpain